FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 316:514-516 February 26, 1987 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We reviewed 519 cases of clear-cell adenocarcinoma of the vagina and cervix identified by the Registry for Research on Hormonal Transplacental Carcinogenesis of the University of Chicago through June 30, 1985. In 60 percent of all cases the patient's mother had received diethylstilbestrol during pregnancy. An additional 12 percent of all mothers had been treated with another hormone or with an unidentified medication. Ninety-one percent of the cases in diethylstilbestrol-exposed women were diagnosed when the patient was between the ages of 15 and 27. The median age at diagnosis was 19.0 years. The risk that clear-cell adenocarcinoma will develop in an exposed female from birth through age 34 is 1 case per 1000 women. The temporal pattern of occurrence of clear-cell adenocarcinoma corresponds closely with that of the use of diethylstilbestrol for pregnancy support in the United States. The rarity of this tumor among exposed women suggests that diethylstilbestrol is not a complete carcinogen and that some other factor is also involved in the pathogenesis of clear-cell adenocarcinoma of the vagina and cervix.

This article has been cited by other articles:

• Bleyer, A. (2007). Young Adult Oncology: The Patients and Their Survival Challenges. CA Cancer J Clin 57: 242-255 [Abstract] [Full Text]  
• Henley, D. V., Korach, K. S. (2006). Endocrine-Disrupting Chemicals Use Distinct Mechanisms of Action to Modulate Endocrine System Function. Endocrinology 147: s25-s32 [Abstract] [Full Text]  
• Cook, J. D., Davis, B. J., Cai, S.-L., Barrett, J. C., Conti, C. J., Walker, C. L. (2005). Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc. Natl. Acad. Sci. USA 102: 8644-8649 [Abstract] [Full Text]  
• Pentheroudakis, G., Pavlidis, N. (2005). Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology. Ann Oncol 16: 181-188 [Abstract] [Full Text]  
• Do, Y., Ryu, S., Nagarkatti, M., Nagarkatti, P. S. (2002). Role of Death Receptor Pathway in Estradiol-Induced T-Cell Apoptosis in Vivo. Toxicol Sci 70: 63-72 [Abstract] [Full Text]  
• Burton, J L, Wells, M (2002). The effect of phytoestrogens on the female genital tract. J. Clin. Pathol. 55: 401-407 [Abstract] [Full Text]  
• Kaufman, R. H., Adam, E. (2002). Findings in Female Offspring of Women Exposed In Utero to Diethylstilbestrol. Obstet Gynecol 99: 197-200 [Abstract] [Full Text]  
• PALMER, J. R., ANDERSON, D., HELMRICH, S. P., HERBST, A. L. (2000). Risk Factors for Diethylstilbestrol-Associated Clear Cell Adenocarcinoma. Obstet Gynecol 95: 814-820 [Abstract] [Full Text]  
• Committee on Drugs, (2000). Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn. Pediatrics 105: 880-887 [Abstract] [Full Text]  
• Hatch, E. E., Palmer, J. R., Titus-Ernstoff, L., Noller, K. L., Kaufman, R. H., Mittendorf, R., Robboy, S. J., Hyer, M., Cowan, C. M., Adam, E., Colton, T., Hartge, P., Hoover, R. N. (1998). Cancer Risk in Women Exposed to Diethylstilbestrol In Utero. JAMA 280: 630-634 [Abstract] [Full Text]